V

Vertex Pharmaceuticals

Develops therapies for serious genetic diseases

Director – Kidney Forecasting & Analytics

Data ScienceConfirmed live in the last 24 hours
Full-timeBoston, MA, USA

About the Job

Requirements

  • Deep expertise across a range of forecasting methodologies and approaches, applying fit-for-purpose methods across early pipeline, launch, and in-line forecasting contexts.
  • Strong analytical and commercial acumen, including structuring ambiguous problems, diagnosing issues, and connecting inputs to strategic implications.
  • Demonstrated experience supporting senior leadership with forecasting, analytics, commercialization planning, and strategic decision-making.
  • Ability to absorb new information quickly, ramp into evolving business contexts, and manage a high volume of complex modeling and planning needs.
  • Strong understanding of market dynamics, competitive landscapes, treatment paradigms, and commercial factors that drive uptake, demand, and performance.
  • Strong understanding of primary market research design and the ability to translate research outputs into forecast assumptions and model architecture.
  • Familiarity with diverse internal and external data sources and the ability to connect them to business questions, forecast design, KPI tracking, and launch planning.
  • Deep understanding of biopharma commercialization, including go-to-market planning, market access, positioning, unmet need assessment, and launch preparation.
  • Ability to synthesize complex information into clear narratives for senior stakeholders.
  • Familiarity and comfort using generative and agentic AI tools to enhance analytical workflows and support deliverables.
  • Advanced Excel modeling skills, including complex forecast model development and refinement.
  • Strong experience working with large and complex data sets.
  • Familiarity with analytical tools and environments such as Snowflake, SQL, Power BI, Python, SAS, and VBA.
  • Experience building models for scenario planning, KPI extraction, performance tracking, and decision-oriented output interpretation.
  • Ability to integrate data, analytics, market research, and competitive insights into practical forecasting frameworks.
  • Bachelor’s degree in a relevant discipline.
  • Minimum 10 years of experience in biotech or pharmaceuticals in a quantitative role within Commercial, Finance, Corporate Strategy, Business Development, Forecasting, or Analytics, or equivalent consulting experience with meaningful biotech/pharmaceutical and quantitative focus.
  • Significant experience supporting forecasting and analytics for complex assets, portfolios, or multiple disease areas.
  • Demonstrated experience working with senior leadership to support commercial planning, financial forecasting, launch planning, and strategic decision-making.
  • Ability to operate effectively in a fast-paced environment, quickly onboard to new business questions, and manage complex modeling demands.

Responsibilities

  • Lead the design, development, refinement, and ongoing evolution of forecasting models across the Kidney portfolio, including current and emerging programs.
  • Support long-range planning, scenario planning, and near-term operational forecasting across multiple disease areas and business questions.
  • Own and enhance forecast frameworks, model logic, core assumptions, analog selections, data inputs, and output structures to keep models decision-useful and adaptable.
  • Translate clinical developments, market events, competitive intelligence, access considerations, epidemiology, and other inputs into forecast assumptions and scenarios.
  • Deliver forecast outputs that clearly articulate key drivers, sensitivities, risks, opportunities, and uncertainties.
  • Serve as a forecasting partner to Marketing and other senior cross-functional stakeholders, providing objective perspective, strategic insight, and forecasting rigor.
  • Synthesize large, complex, and evolving data sets into actionable recommendations for senior leadership.
  • Maintain understanding of the evolving kidney market, including treatment dynamics, patient flow, competitive shifts, and the landscape for the company’s assets.
  • Support analyses of market opportunity, demand evolution, treatment patterns, and patient movement across existing and emerging therapies.
  • Ensure key performance indicators can be derived from forecast models and used to explain and track forecasted performance.
  • Build forecast structures that enable transparent performance drivers, clear interpretation of outputs, and effective scenario assessment.
  • Use internal and external data sources to support forecasting assumptions and align with portfolio data and analytics needs.
  • Partner with Marketing, Global Pricing and Market Access, Finance, HEOR, Marketing Science, Medical, Clinical, Commercial Strategy, and regional teams to align on assumptions and planning needs.
  • Help shape market research and analytics inputs for forecast assumptions and business decision-making.
  • Translate primary market research and analytics outputs into forecast structure, assumptions, and strategic recommendations.
  • Provide forecasting and analytical support for commercialization planning, launch readiness, lifecycle planning, and portfolio prioritization.
  • Operate with urgency and sound judgment, onboarding rapidly to new questions and delivering analyses under tight timelines.

Desired Qualifications

  • Advanced degree.
  • Experience supporting global brands and global markets.
  • Experience in kidney disease or adjacent therapeutic areas.
  • Prior in-line forecasting experience.

About the Company

Vertex Pharmaceuticals

Develops therapies for serious genetic diseases

Vertex Pharmaceuticals develops medicines for serious diseases, with a focus on cystic fibrosis. It conducts extensive research and partners with other biotech firms to discover and develop new therapies, including ex vivo engineered cell treatments. Its products, such as ivacaftor, treat cystic fibrosis and other therapies undergo clinical testing to expand the pipeline. Revenue comes from selling approved drugs and from licensing and collaboration agreements. The company distinguishes itself through deep R&D investment, strategic partnerships, and a global reach aimed at addressing unmet medical needs. The overall goal is to bring effective new drugs to patients worldwide and improve outcomes and quality of life.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boston, MA
Founded
1989

Recently Posted Jobs

Explore more opportunities at Vertex Pharmaceuticals

See more jobs